Psychiatry and Neurology, Neurology · Newark, DE
NPI
1255622676
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Hygeia Dr Ste 1420
Newark, DE, 19713
Phone (302) 623-3017
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
7,915 services
Medicare patients, 2024
682
Average age 76
Drug cost, 2024
$2.0M
4,029 prescriptions
Company payments, 2025
$164K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Justin P Martello was code J0585 (injection, onabotulinumtoxina, 1 unit), 5,100 times for 15 patients. In total Justin P Martello billed 7,915 services in 32 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,100 | 15 | $4.85 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 286 | 275 | $12.54 | $3,587 |
| 99214 Office E&M - Established | Facility | 221 | 193 | $67.66 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 218 | 202 | $12.56 | $2,738 |
| 99214 Office E&M - Established | Office | 155 | 141 | $87.32 | $14K |
| 99215 Office E&M - Established | Facility | 112 | 103 | $102.92 | $12K |
| 99215 Office E&M - Established | Office | 79 | 70 | $136.13 | $11K |
| 99213 Office E&M - Established | Facility | 74 | 65 | $44.99 | $3,329 |
| 64616 Musculoskeletal | Facility | 72 | 27 | $99.82 | $7,187 |
| 99213 Office E&M - Established | Office | 51 | 49 | $59.03 | $3,011 |
| 95874 Musculoskeletal | Facility | 49 | 23 | $13.65 | $669 |
| 99205 Office E&M - New | Facility | 42 | 42 | $126.56 | $5,315 |
| 95983 Electrical Nerve Conductivity | Facility | 37 | 23 | $30.82 | $1,141 |
| 64612 Musculoskeletal | Facility | 33 | 14 | $125.74 | $4,149 |
| 99205 Office E&M - New | Office | 30 | 30 | $155.97 | $4,679 |
By year: 2022 $99K for 6,164 services; 2023 $136K for 7,476 services; 2024 $138K for 7,915 services.
Medicare prescription drug claims, 2024
In 2024, the drug Justin P Martello prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 768 prescriptions and refills. In total Justin P Martello wrote 4,029 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 768 | 2,046 | 264 | $46K |
| Clonazepam Generic | 262 | 575 | 76 | $3,159 |
| Rytary Carbidopa/Levodopa | 229 | 338 | 52 | $354K |
| Amantadine Amantadine Hcl | 194 | 455 | 81 | $13K |
| Rivastigmine Rivastigmine Tartrate | 156 | 326 | 50 | $12K |
| Primidone Generic | 153 | 405 | 47 | $5,413 |
| Propranolol Hcl Generic | 141 | 394 | 43 | $7,881 |
| Quetiapine Fumarate Generic | 135 | 288 | 45 | $2,819 |
| Gabapentin Generic | 128 | 296 | 38 | $2,654 |
| Memantine Hcl Generic | 109 | 257 | 37 | $3,581 |
| Gocovri Amantadine Hcl | 94 | 112 | 14 | $308K |
| Donepezil Hcl Generic | 90 | 220 | 33 | $3,558 |
| Propranolol Hcl Er Propranolol Hcl | 83 | 192 | 30 | $4,728 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 82 | 186 | 24 | $1,342 |
| Nuplazid Pimavanserin Tartrate | 78 | 96 | 16 | $420K |
Brand drugs: 641 claims; generic drugs: 3,373 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Justin P Martello $164K ($164K in general payments such as food, travel and fees) from 12 companies. The largest payer was ACADIA Pharmaceuticals Inc with $57K.
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc ACAD | 63 | $57K |
| Teva Pharmaceuticals USA, Inc. TEVA | 28 | $46K |
| Neurocrine BioSciences, Inc. NBIX | 31 | $29K |
| Abbvie Inc. ABBV | 35 | $20K |
| MDD US Operations, LLC | 7 | $4,143 |
| Amneal Pharmaceuticals LLC AMRX | 8 | $2,669 |
| InSightec,Inc | 22 | $2,452 |
| Boston Scientific Corporation BSX | 6 | $1,416 |
| Medtronic, Inc. MDT | 10 | $943 |
| Abbott Laboratories ABT | 3 | $288 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.